Johnson & Johnson's COVID-19 vaccine, on pause for more than a week, is nearing another green light

With few additional cases of rare and serious blood clots seen over the last several days, health officials in the United States are expected to recommend the resumption of Johnson & Johnson's COVID-19 vaccine rollout.

Resumption of the shot will likely come with a warning about the unusual side effect which has stricken roughly one in every million of those who have received the vaccine, The New York Times reports.